Last update 26 Dec 2024

XNW-27011

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
XNW 27011, XNW-27011, XNW27011
Target
CLDN18.2
Mechanism
CLDN18.2 inhibitors(Claudin 18.2 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Biliary Tract NeoplasmsColonic CancerEsophageal Carcinoma+ [5]
Inactive Indication-
Originator Organization
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
Active Organization
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.StartupShanghai Sinovent Biopharmaceutical Co., Ltd
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationFast Track (US)
Login to view timeline

Related

1
Clinical Trials associated with XNW-27011
CTR20231735 / RecruitingPhase 1
XNW27011在局部晚期或转移性实体瘤患者中的首次人体Ⅰ/Ⅱ期研究
[Translation] A first-in-human phase I/II study of XNW27011 in patients with locally advanced or metastatic solid tumors
100 Clinical Results associated with XNW-27011
Login to view more data
100 Translational Medicine associated with XNW-27011
Login to view more data
100 Patents (Medical) associated with XNW-27011
Login to view more data
100 Deals associated with XNW-27011
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Biliary Tract NeoplasmsPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Colonic CancerPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Esophageal CarcinomaPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Lung CancerPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Ovarian CancerPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Pancreatic Ductal AdenocarcinomaPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Stomach CancerPhase 2
US
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.Startup
01 Jan 2023
Solid tumorPhase 1
CN
Shanghai Sinovent Biopharmaceutical Co., Ltd
24 Jul 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free